VJ

Vandana Jain Agarwal

Active Director Director DIN 05310542
DIN 05310542 First appointment Feb 2015 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2015
Shareholding value •••• Premium profile

About Vandana Jain Agarwal

Data last updated:

Vandana Jain Agarwal is a Director at Encure Medical Private Limited (since 2015). The company operates in Pharma. Encure Medical Private Limited reported revenue of ₹35,452 (FY 2025).

DIN 05310542
Primary Designation Director
Industry Pharma
First Appointment 14 Feb 2015
Oldest Company Age 11 yrs
Largest company Encure Medical Private Limited · ₹35,452 (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Encure Medical Private Limited U74120MH2015FTC261892
Director14 Feb 20152015₹35,452 (FY 2025)Active

Board colleagues of Vandana Jain Agarwal

Directorship timeline

Open interactive timeline →
Encure Medical Private Limited
Premium access

Shareholding and investment profile for Vandana Jain Agarwal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vandana Jain Agarwal

Vandana Jain Agarwal currently holds 1 directorship: Encure Medical Private Limited (Director, since 14 Feb 2015, revenue ₹35,452 (FY 2025)).

Vandana Jain Agarwal was first appointed on 14 Feb 2015 as Director at Encure Medical Private Limited.

The current boards of Vandana Jain Agarwal's companies include Prakashchandra Shikharchand Jain (Encure Medical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available